C

Compass Therapeutics
D

CMPX

1.55500
USD
0.04
(2.64%)
Market Closed
Volume
64,380
EPS
-0
Div Yield
-
P/E
-4
Market Cap
213,951,161
OverviewSignalsIdeasNews
Related Instruments
    XEMUSD
    XEMUSD
    0.001178
    (6.30%)
    0.019766 USD
    AEM
    AEM
    -0.900
    (-1.16%)
    76.740 USD
    A
    AG
    -0.12000
    (-1.86%)
    6.33500 USD
    F
    FNV
    -1.320
    (-1.15%)
    113.960 USD
    F
    FSM
    -0.02500
    (-0.53%)
    4.67500 USD
    GOLD
    GOLD
    -0.220
    (-1.30%)
    16.650 USD
    N
    NEM
    0.235
    (0.58%)
    40.910 USD
    S
    SSRM
    -0.01000
    (-0.18%)
    5.51000 USD
    More
News

Title: Compass Therapeutics

Sector: Healthcare
Industry: Biotechnology
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.